BioVentures

What BioVentures does

BioVentures LLC is the official technology transfer office of the University of Arkansas for Medical Sciences (UAMS), headquartered at 401 South Cedar Street in Little Rock, Arkansas. Founded in 1994, the organization manages the full intellectual property lifecycle for inventions generated at UAMS, including identification, protection (patents, copyrights, trademarks), licensing, and commercialization. Its core deliverable is technology transfer services rather than a standalone product, and its revenue mechanics combine negotiated licensing royalties, startup incubation support (with possible equity), and grant funding such as the NCI R25 grant supporting the CADET program and the $15,000 Chancellor's Circle Grant awarded in November 2025. A 2023 grant of approximately $3.0M from the Minority Business Development Agency also appears in the data.

The technology portfolio under BioVentures' stewardship spans therapeutics, diagnostics, medical devices, and healthcare software. Notable assets include a granted U.S. patent (No. 12,582,374 B2) on personalized AI-guided motion-gated coronary CTA scanning using four-dimensional CT and machine-learning motion prediction; a granted patent on combretastatin-A4 methods to reduce protein aggregation in neurodegenerative disease via GFAP binding; a granted immersive distraction therapy patent for surgical anxiety; a granted amblyopia patch; and a filed ARGUS intelligent radiation safety device. The organization distributes these technologies through a browseable Tradespace portal, direct licensing negotiations, and startup formation, and supports them with structured programs: CADET (NIH-funded cancer-researcher training), MIEHT (four-year medical student innovation honors), the AR Health Ventures Accelerator (therapeutic projects with up to $50,000 per project), and the Founder's Forum peer group via an ARise partnership.

BioVentures is a private LLC government/state-funded through its parent institution, with no external venture capital or private equity investors. It operates with 1–10 employees, is led by President Eric Peterson alongside a small leadership team, and serves the Arkansas healthcare innovation ecosystem with regional event participation (Bio on the Bayou, AUTM, Innovation Day 2026, Healthcare Innovation Sprint 2026). Marketing is conducted through a podcast, blog, email newsletter, and broad social media presence, while distribution to licensees occurs through the Tradespace portal, direct negotiations, and startup incubation channels.

Name

BioVentures

Legal name

BioVentures LLC

Website

https://bioventures.tech

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

BioVentures is the technology transfer office of the University of Arkansas for Medical Sciences, managing intellectual property, licensing, and startup incubation for UAMS researchers and Arkansas healthcare startups across therapeutics, diagnostics, devices, and software.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE)

Keywords

• Technology transfer services
• Intellectual property licensing
• University research commercialization
• Healthcare startup incubation
• Biotech accelerator programs

Headquarters

HQ city

Arkansas City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Technology Licensing: Development of licensing strategies, negotiation of licensing agreements, and oversight of existing agreements to ensure compliance and manage royalties from commercialization of UAMS technologies.
2. Startup Incubation and Equity: Providing support for new business creation including entrepreneurial guidance, access to incubator space, and connecting to potential investors. May include equity stakes in startup companies.
3. Grant Funding: Securing grant funding such as the Chancellor's Circle Grant and NCI R25 grant for CADET program to support training and innovation activities.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels13 records

Core offering

BioVentures is the technology transfer office of the University of Arkansas for Medical Sciences (UAMS) and manages intellectual property generated at the institution. It provides IP management, patent filing and maintenance, licensing strategy and agreement negotiation, commercialization support, startup incubation, funding and grant assistance, industry partnership facilitation, and compliance guidance for UAMS researchers and healthcare startups.

Product overview

BioVentures serves as the technology transfer office of the University of Arkansas for Medical Sciences (UAMS), offering a comprehensive portfolio of innovation support services. The core offering encompasses intellectual property management, licensing, commercialization strategies, and startup incubation. The portfolio includes specialized programs: CADET (Cancer and Developing Entrepreneurial Technologies) for cancer researchers, MIEHT (Medical Innovation and Entrepreneurship Honors Track) for medical students, the AR Health Ventures Accelerator for therapeutic development, and the Founder's Forum for startup support. Additional offerings include the BioVentures Podcast for innovation storytelling and Innovation Awards for student recognition. Together, these programs form a complete ecosystem supporting researchers from invention disclosure through commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• CADET: Cancer and Developing Entrepreneurial Technologies - a training program guiding cancer researchers through translating discoveries into market-ready technologies
• MIEHT
• AR Health Ventures Accelerator
• Founder's Forum
• BioVentures Podcast

Products and services

• Technology Transfer Office Services Comprehensive technology transfer services for UAMS inventors, including intellectual property identification, patent filing and maintenance, copyright and trademark protection, licensing strategy and agreement negotiation, commercialization support, startup incubation, funding and grant assistance, industry partnership facilitation, compliance and regulatory guidance, and educational programs on IP and entrepreneurship.
• CADET (Cancer and Developing Entrepreneurial Technologies) Program NIH R25 grant-supported year-long training program that equips UAMS cancer researchers, clinicians, and trainees with foundational knowledge in healthcare innovation, intellectual property, and commercialization. Pairs participants with BioVentures staff and industry mentors.
• MIEHT (Medical Innovation and Entrepreneurship Honors Track) Four-year honors program for UAMS medical students that prepares future physicians to identify unmet clinical needs and develop solutions with real-world impact and commercialization potential. Upon completion, students receive an honors designation on their diploma.
• AR Health Ventures Accelerator (ARHVA) Therapeutic accelerator program that accelerates development of projects from scientific discovery to commercialization, providing consultancy, guidance, and funding of up to $50,000 to selected UAMS therapeutic projects in drugs, diagnostics, and devices. Focuses on de-risking discoveries and enhancing commercial potential.
• Founder's Forum Curated peer group for UAMS startup founders providing practical support for real business problems including customer discovery, go-to-market, hiring, fundraising, and execution. Delivered through BioVentures in partnership with ARise, with 1:1 expert support from paid subject matter experts.
• BioVentures Podcast Conversations with inventors, entrepreneurs, and experts turning science into innovation. Available on Spotify and other podcast platforms.
• BioVentures Innovation Awards Awards presented during UAMS Student Research Day recognizing students whose research reflects creativity, scientific excellence, and interest in translational science.
• Technology Licensing Portfolio Browseable portfolio of UAMS intellectual property available for licensing and commercialization, accessible through the Tradespace portal at https://bioventures.portals.in-part.com, covering therapeutics, diagnostics, medical devices, research tools, healthcare software, and copyrights.

Quantifiable outcome

• ARHVA projects can receive up to $50,000 in managed funding support
• +2 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• ARise (Arkansas Innovators, Startups, and Entrepreneurs)coreStrategic or Co-development PartnerARise is a program supporting Arkansas innovators, startups, and entrepreneurs backed by the Arkansas Economic Development Commission (AEDC). BioVentures partners with ARise to provide the Founder's Forum peer group for UAMS startup founders and access to 1:1 expert support through paid subject matter experts. ARise assists tech and tech-enabled companies in reaching new levels of success.
• ConductorminorStrategic or Co-development PartnerConductor hosts the Healthcare Innovation Sprint in partnership with BioVentures, Arkansas INBRE, and UAMS. This four-day immersive program for Arkansas college students focuses on healthcare innovation and entrepreneurship.
• Arkansas INBREminorStrategic or Co-development PartnerArkansas INBRE (IDeA Networks of Biomedical Research Excellence) partners with BioVentures on the Healthcare Innovation Sprint program for Arkansas college students.
• University of Central ArkansasminorStrategic or Co-development PartnerHost venue for the Healthcare Innovation Sprint 2026 (May 11-14) at University of Central Arkansas, in partnership with BioVentures.
• AUTM (Association of University Technology Managers)minorStrategic or Co-development PartnerBioVentures participates in AUTM University Conference and Annual Meeting, professional development events for technology transfer offices across the country to exchange knowledge and explore emerging trends.
• Bio on the BayouminorStrategic or Co-development PartnerBioVentures attends Bio on the Bayou, a leading regional event in New Orleans bringing together innovators, researchers, and investors to showcase advances in biotechnology, medtech, and health sciences.
• Ark Angel AllianceminorImplementation/ SI/ Consulting PartnerArk Angel Alliance, led by Executive Director Melissa Kempkes, provides subject matter expertise to the Founder's Forum program. As an ARise partner, Ark Angel Alliance supports UAMS biotech founders with fundraising strategies and investor connections.
• UAMS (University of Arkansas for Medical Sciences)coreOthersBioVentures is the official technology transfer office of UAMS, responsible for managing all intellectual property generated at the institution.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Johns Hopkins Technology Ventures: The technology transfer office for Johns Hopkins University, managing IP, licensing, and startup formation across a much larger academic medical and research portfolio. Directly comparable as a peer university TTO operating with the same mandate for academic biomedical IP.
• Stanford Office of Technology Licensing: Stanford University's central technology licensing office, handling invention disclosure, patenting, and licensing for one of the most prolific academic invention engines in the world. Directly comparable TTO model.
• MIT Technology Licensing Office: MIT's technology licensing office managing patents, copyright, and licensing for MIT research output, including significant biomedical and life sciences inventions. Same academic TTO function with similar disclosure-to-license workflow.
• Duke Office of Licensing & Ventures: Duke University's TTO responsible for evaluating, protecting, and licensing inventions from Duke faculty, with a strong emphasis on therapeutics, devices, and diagnostics. Closely aligned peer in academic medical center IP management.
• Vanderbilt Center for Technology Transfer and Commercialization: Vanderbilt's TTO that protects, markets, and licenses IP arising from Vanderbilt research, with notable strength in biomedical and life sciences. Comparable peer institution TTO with similar scale and academic medical center focus.
• University of Michigan Innovation Partnerships: University of Michigan's technology transfer and industry engagement office, managing IP and licensing for one of the largest public research universities. Comparable in mandate and in running a multi-program startup formation ecosystem.
• Emory Office of Technology Transfer: Emory University's TTO providing IP management and licensing services to faculty, with a portfolio heavily weighted toward biomedical and life sciences inventions. Directly comparable academic TTO peer.
• Penn Center for Innovation: University of Pennsylvania's technology transfer office responsible for IP management, licensing, and startup support across the university, with a substantial biomedical portfolio. Closely aligned TTO peer.
• Washington University Office of Technology Management: Washington University in St. Louis's TTO that evaluates, patents, and licenses faculty inventions, with particular strength in biomedical and life sciences. Comparable academic TTO serving a research-intensive medical center.
• UCSF Office of Technology Management: UCSF's TTO managing invention disclosure, patenting, and licensing for one of the leading health sciences universities. Directly comparable TTO focused exclusively on biomedical and health sciences IP.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BioVenturesAR
• YouTubeyoutube.com/@BioVentures.
• Facebookfacebook.com/people/BioVentures-LLC/100093813505517
• LinkedInlinkedin.com/company/16247170/admin/feed/posts
• Instagraminstagram.com/bioventures_arkansas

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioVentures